Apellis Pharmaceuticals layoffs, on the record
Every job cut, severance charge and restructuring Apellis Pharmaceuticals reported in its annual reports, 2023 to 2025, quoted from the filings.
Job cuts, severance and restructuring
Our summaryAnnounced a corporate restructuring and cost savings initiative that included a workforce reduction.
Word for word“In August 2023, we announced that we were conducting a corporate restructuring and cost savings initiatives involving a headcount reduction of approximately 225 employees, or approximately 25% of our then current workforce.” 10-K for 2023
Our summaryCompleted the workforce reduction, which was substantially finished in the third quarter of 2023.
Word for word“Our workforce reduction was substantially completed in the three months ended September 30, 2023.” 10-K for 2023
Apellis Pharmaceuticals filed 1 restructuring notice (Form 8-K, Item 2.05) since 2016. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from Apellis Pharmaceuticals’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-24. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.